Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy Study in Removing Excess Iron From the Heart
This study has been completed.
Study NCT00105495   Information provided by ApoPharma
First Received: March 15, 2005   Last Updated: March 13, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Thalassemia Major
Hemosiderosis
Additional conditions recognized in this trial
Beta-Thalassemia
Thalassemia
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Iron Metabolism Disorders
Iron Overload
Metabolic Diseases
Interventions listed in this trial
Ferriprox (deferiprone)
Desferal (deferoxamine)
Additional drug interventions recognized in this trial
Deferiprone
Deferoxamine
More general drug interventions related to this trial
Chelating Agents
Iron Chelating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Siderophores
Sponsors listed in this trial
ApoPharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services